Skip to content

    HARVARD BIOSCIENCE (HBIO) stock price & financials

    View HBIO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+48.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $21.97M
    $24.56M
    $21.77M
    $20.45M
    $20.59M
    -6.3%
    $23.73M
    -3.3%
    $20.75M
    -4.7%
    $22.73M
    +11.1%
    Stable
    Operating Profit
    -$1.87M
    $11.0K
    -$49.67M
    -$819.0K
    $197.0K
    $1.71M
    +15445.5%
    -$1.17M
    +97.6%
    -$978.0K
    -19.4%
    Strengthening
    Net Profit
    -$4.80M
    $18.0K
    -$50.34M
    -$2.28M
    -$1.23M
    +74.4%
    -$2.85M
    -15916.7%
    -$3.42M
    +93.2%
    -$2.91M
    -27.5%
    Weakening
    EPS
    $-0.11
    $-11.42
    $-0.52
    $-0.03
    +72.7%
    $-0.77
    +93.3%
    $-0.64
    -23.1%
    Strengthening
    Other Income
    -$2.62M
    $579.0K
    -$1.13M
    -$1.44M
    -$1.33M
    +49.1%
    -$4.91M
    -948.7%
    -$2.13M
    -89.4%
    -$1.92M
    -33.7%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$4.49M
    $590.0K
    -$50.79M
    -$2.25M
    -$1.13M
    +74.7%
    -$3.20M
    -643.1%
    -$3.31M
    +93.5%
    -$2.90M
    -28.5%
    Weakening
    MarginsOPM
    -8.5%
    0.0%
    -228.1%
    -4.0%
    1.0%
    7.2%
    +17900.0%
    -5.7%
    +97.5%
    -4.3%
    -7.5%
    Strengthening
    Tax
    -6.9%
    97.0%
    0.9%
    -1.2%
    -8.6%
    -23.6%
    11.1%
    -88.5%
    -3.5%
    -497.8%
    -0.5%
    +61.3%
    Weakening
    ReturnsROIC
    2.2%
    -0.0%
    22.8%
    1.0%
    0.6%
    -74.4%
    1.3%
    1.6%
    -93.2%
    1.3%
    +27.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$8.17M$8.34M$8.32M$7.82M$4.51M$4.28M$4.11M$8.61M$6.50M
    Short-Term Investments
    Total Current Assets$57.83M$53.57M$51.70M$61.58M$51.12M$49.04M$45.12M$48.23M$46.46M
    Net PP&E$5.90M$13.24M$11.72M$10.31M$9.18M$8.75M$11.24M$11.96M$11.75M
    Goodwill$57.30M$57.38M$58.59M$57.69M$56.26M$57.06M$56.32M$9.56M$9.33M
    Intangibles$45.76M$38.41M$33.15M$27.39M$21.01M$16.04M$11.13M$7.64M$6.22M
    Total Assets$168.61M$164.87M$156.25M$162.34M$145.36M$137.37M$126.64M$80.07M$76.29M
    LiabilitiesTotal Current Liabilities$25.49M$25.31M$21.05M$25.32M$23.25M$26.54M$54.96M$21.96M$24.79M
    Short-Term Debt$2.40M$3.20M$2.00M$3.52M$4.09M$6.14M$36.96M$0$0
    Long-Term Debt$54.81M$46.92M$46.29M$45.09M$43.01M$30.70M$0$35.87M$36.68M
    Long-Term Leases$0$8.22M$7.48M$6.49M$5.28M$4.79M$6.38M$6.88M$5.93M
    Total Liabilities$85.89M$83.18M$79.57M$78.94M$73.14M$64.29M$63.30M$66.34M$68.87M
    EquityCommon Stock & APIC$436.0K$438.0K$444.0K$452.0K$454.0K$434.0K$441.0K$447.0K$447.0K
    Retained Earnings-$119.89M-$124.58M-$132.39M-$132.67M-$142.19M-$145.60M-$158.01M-$214.71M-$221.04M
    Total Equity$82.72M$81.69M$76.68M$83.40M$72.22M$73.07M$63.34M$13.73M$7.42M
    HighlightsNet Cash / (Debt)-$49.04M-$41.78M-$39.97M-$40.79M-$42.60M-$32.56M-$32.85M-$27.26M-$30.18M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$2.88M$8.04M$9.33M$1.26M$1.15M$14.03M$1.44M$6.73M$651.0K
    Cash from Investing-$53.80M-$229.0K-$1.40M-$1.34M-$1.59M-$1.80M-$1.34M-$1.86M-$2.48M
    Cash from Financing$53.05M-$7.62M-$7.97M-$252.0K-$2.84M-$12.13M-$131.0K-$1.29M$1.12M
    SummaryCapital Expenditure-$986.0K-$1.22M-$1.15M-$1.20M-$1.59M-$1.79M-$2.64M-$1.26M-$1.77M
    Free Cash Flow$1.90M$6.83M$8.18M$67.0K-$438.0K$12.24M-$1.20M$5.47M-$1.12M
    FCF Margin1.6%5.9%8.0%0.1%-0.4%10.9%-1.3%6.3%-1.3%

    Ratios